Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- Patients followed at Mayo Clinic and treated for sarcoma with doxorubicin as first-line treatment.
- First-line treatment not including doxorubicin
- Treatment performed outside of Mayo Clinic with different protocols
- Age <18 years
- Subjects unable or unwilling to provide the written consent
- LVEF <50%,